Inactive

Amendment #002, dated September 26, 2023. See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions remain the same. The due date has been changed to 9:00 am EDT on Wednesda... Amendment #002, dated September 26, 2023. See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions remain the same. The due date has been changed to 9:00 am EDT on Wednesday, September 27, 2023. This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ). The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC). The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.